Cytotoxic and Biomolecular Study of Five Plant Extracts Against Different Human Cancer Cell Lines // GP // Prof. Ayman Diab // Dr. Gehan Safwat // Dr. Salwa El-Hallouty (2017-2018) الدراسة السمية والجزيئية للخاليا من خمس مستخلصات نباتية ضد خطوط الخاليا السرطانية البشرية المختلفة
Material type: TextSeries: BIOTECHNOLOGY DISTINGUISHED PROJECTS 2018Publication details: Giza MSA 2018Description: 74 P. 30 CMSubject(s): DDC classification:- 612
Item type | Current library | Call number | Status | Notes | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Distinguished Graduation Projects | Centeral Library Soft Copy located on library Cataloge | GP402BIO2018 (Browse shelf(Opens below)) | Available | 612 | 81824 |
Browsing Centeral Library shelves, Shelving location: Soft Copy located on library Cataloge Close shelf browser (Hides shelf browser)
Biotechnology
Natural products offer a wide variety of chemical structures
with different biological activities that can be used for the
development of novel drugs. Around 60% of the current
anticancer drugs were isolated from natural products. In this study, it is attempted
to exploit five plant extracts, Euphorbia hierosolymitana (herb), Sapium sebifera
(branch), Cordyline fruticosa (leaf and branch), Dracerna marginata (bark) and
Dracaena marginata (leaf and branch), and show their cytotoxic activities on
different human cancer cell line including breast carcinoma (MCF-7), hepatocellular
carcinoma (HepG2), colon carcinoma (HCT116) and prostate cancer (PC3), and
normal skin cell line (BJ-1). Methanol extracts of these plants underwent MTT
cytotoxic assay and found that E. hierosolymitana selectively inhibited HCT116 cell
proliferation with IC50 of 4.22 μg/ml, both Dracaena marginata extracts showed
moderate cytotoxicity on MCF-7 with IC50 of 22.4 and 48.2 μg/ml, respectively. The
remaining two extracts showed minimal to insignificant percentage inhibition on all
There are no comments on this title.